Written by MarketBeatSeptember 4, 2025 ShareLink copied to clipboard. Key Points Robot Consulting, BigBear.ai, and Carisma Therapeutics are highlighted as the top penny stocks to watch, each showing significant trading volume in recent days. Robot Consulting focuses on human resource solutions and plans to expand into legal tech and the metaverse, featuring a cloud-based management system. Carisma Therapeutics is a clinical-stage company working on CAR-M cell therapies for cancer treatments, with multiple therapies in various stages of clinical trials. Five stocks we like better than Robot Consulting. Like this article? Share it with a colleague. Link copied to clipboard. Featured Articles and OffersJoby Aviation's Pullback: A Gift for Investors Who See the FutureBy Jeffrey Neal Johnson | September 2, 2025What's the Best Way to Lower RMD Taxes?From SmartAsset (Ad)Lucid Group (NASDAQ:LCID) Given New $30.00 Price Target at Morgan StanleyBy MarketBeat | September 5, 2025Top 5 September Stock Picks: Market Tailwinds Drive New MomentumBy Thomas Hughes | September 1, 2025Smaller Industrials Names Seeing Surging Growth: Here's WhyBy Nathan Reiff | August 30, 2025REVEALED FREE: Our top 3 stocks to own in 2025 and beyondFrom Weiss Ratings (Ad)Jefferies Financial Group Has Lowered Expectations for lululemon athletica (NASDAQ:LULU) Stock PriceBy MarketBeat | September 5, 20253 Tariff-Proof Retailers Making New All-time HighsBy Dan Schmidt | September 1, 2025 Recent Videos Stock ListsAll Stock Lists5G Biotech Blue Chip FAANG Gold Large Cap Marijuana Micro Cap Oil REITs Russell 2000 Small Cap Warren Buffett Investing ToolsCalendars and ToolsAnalyst RatingsCryptocurrency ScreenerCongressional TradingDividend IncreasesDividend CalculatorDividend CalendarEarnings AnnouncementsInsider TradesOptions Profit CalculatorPenny StocksPortfolio MonitoringShort InterestStock ComparisonsStock Market HolidaysStock Screener Search Headlines Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Written by MarketBeatSeptember 4, 2025 ShareLink copied to clipboard. Key Points Robot Consulting, BigBear.ai, and Carisma Therapeutics are highlighted as the top penny stocks to watch, each showing significant trading volume in recent days. Robot Consulting focuses on human resource solutions and plans to expand into legal tech and the metaverse, featuring a cloud-based management system. Carisma Therapeutics is a clinical-stage company working on CAR-M cell therapies for cancer treatments, with multiple therapies in various stages of clinical trials. Five stocks we like better than Robot Consulting. Like this article? Share it with a colleague. Link copied to clipboard.
